# reload+after+2024-01-21 12:29:47.570652
phone§(877) 756-PURE
longBusinessSummary§The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
maxAge§86400
priceHint§2
yield§0.0123000005
totalAssets§12782947
navPrice§19.6213
currency§USD
category§Health
ytdReturn§0.002638
beta3Year§0.98
fundFamily§ETFMG
fundInceptionDate§1592352000
legalType§Exchange Traded Fund
threeYearAverageReturn§-0.1438266
exchange§PCX
quoteType§ETF
shortName§ETFMG Treatments Testing and Ad
longName§ETFMG Treatments, Testing and Advancements ETF
firstTradeDateEpochUtc§1592487000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§30e943a6-9343-348f-940a-98983f28da0a
gmtOffSetMilliseconds§-18000000
trailingPegRatio§None
